Onconova Therapeutics: Funding, Investors & Team (Sep 2026)
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
Onconova Therapeutics has raised $21.0M across 1 funding round on record, the most recent a Post-IPO Equity of $21.0M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onconova Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Onconova Therapeutics Funding Rounds
Onconova Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Onconova Therapeutics Funding Compared to Other Biotechnology Startups
Onconova Therapeutics' latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onconova Therapeutics in Biotechnology and Newtown
Companies Similar to Onconova Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Onconova Therapeutics Funding FAQs
What does Onconova Therapeutics do?
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
How much funding has Onconova Therapeutics raised?
Onconova Therapeutics has raised $21.0M across 1 round on record. The most recent is a Post-IPO Equity of $21.0M announced in Sep 2021.
When did Onconova Therapeutics last raise funding?
Onconova Therapeutics' most recent funding round on record is a Post-IPO Equity of $21.0M, announced in Sep 2021.
Who is the CEO of Onconova Therapeutics?
Steven Fruchtman is listed as CEO at Onconova Therapeutics.
Where is Onconova Therapeutics headquartered?
Onconova Therapeutics is based in Newtown, Pennsylvania, United States.
How many employees does Onconova Therapeutics have?
Onconova Therapeutics is in the 11-50 employee band.
How does Onconova Therapeutics' funding compare to other Biotechnology startups?
Onconova Therapeutics' latest round of $21.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Onconova Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onconova Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.